Table V. Summary of literature reports on paclitaxel and cetuximab for squamous cell carcinoma of head and neck.

ORR, Overall response rate; DCR, disease control rate; PFS, progression-free survival; OS, overall survival. *ORR, DCR, PFS, and OS are combinations of first-line and second-line therapy. **Grade 2 and higher.